ORIENTBIO Trading Halt and Resumption Due to Capital Reduction Over 10%
ORIENTBIO experienced a short trading halt from 16:14 on June 23, 2026 to 09:00 on June 24, 2026 due to a material disclosure.
The halt was triggered by a capital reduction exceeding 10%, significantly reducing the number of outstanding shares and enhancing shareholder value.
With a reduction ratio over 10%, this measure is expected to boost earnings per share and stock price, though the specific method and management intent require further clarification.
Investors should note that after-hours trading before the resumption date is not permitted, so trading will only resume during regular hours.
[AI Summary]ORIENTBIO's capital reduction of over 10% is a strong signal to enhance existing shareholder value, eliminating dilution concerns and increasing per-share value. The brief trading halt offers investors a chance to reassess, likely leading to positive stock price momentum.
KOSPI Filing Information
Trading Suspension and Lifting of Suspension (Disclosure of Material Information)